Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties by Quentin Van Thillo, Cédric Hermans

Get full text

Extravascular factor IX after gene therapy in hemophilia B, does it matter? by Quentin Van Thillo, Cédric Hermans

Get full text

New horizons in the pharmacological management of venous thromboembolism by Andreas Verstraete, Quentin Van Thillo, Thomas Vanassche, Peter Verhamme

Get full text

Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case series by Quentin Van Thillo, Finn Segers, Jan Brijs, Ulrike Douven, Radha Ramanan, Michel Delforge, Ann Janssens, Cédric Hermans, Johan De Bent, Marc Jacquemin, Thomas Vanassche, Peter Verhamme

Get full text

Clinical utility of panel-based genetic sequencing for von Willebrand disease by Radha Ramanan, Christine Van Laer, Sarissa Baert, Cyrielle Kint, Chris Van Geet, Quentin Van Thillo, Peter Verhamme, Thomas Vanassche, James D. McFadyen, Andrew C. Perkins, Huyen A. Tran, Veerle Labarque, Kathleen Freson

Get full text